KNIGHT JEFF E.

PrivateCIK: 1881007
Location

SAN DIEGO, CA

KNIGHT JEFF E. (Chief Operating Officer) sold 44.7% of their position (85.16K shares) of CRINETICS PHARMACEUTICALS, INC. on the open market

Open‑market sale worth $3.42M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 1 sale
InsiderKNIGHT JEFF E.CIK 1881007
Officer· Chief Operating Officer
Since Aug 2021
-85.16K
Net shares
Net seller
$3.42M
Total sold
1
Open market trades
0B · 1S
7
Total transactions
78.43K acquired · 163.60K disposed
Non-Derivative Transactions4

Common Stock

Direct
M · Option Exercise

Shares

+49.47K

Price / share

$23.98

Trade value

$1.19M

% of position

44.2%
4/8/2026
112.02K161.49K

Common Stock

Direct
M · Option Exercise

Shares

+9.62K

Price / share

$20.02

Trade value

$192.67K

% of position

6.0%
4/8/2026
161.49K171.12K

Common Stock

Direct
M · Option Exercise

Shares

+19.34K

Price / share

$19.64

Trade value

$379.76K

% of position

11.3%
4/8/2026
171.12K190.45K

Common Stock

Direct
S · Sale

Shares

85.16K

Price / share

$40.10

Trade value

$3.42M

% of position

44.7%
4/8/2026
190.45K105.29K
Total

Net shares

6.73K

Net value

-$1.66M

Derivative Transactions3

Stock Option (Right to Buy)

Direct
M · Option Exercise
Converts to

Common Stock

49.47K shares

Shares

49.47K

Strike price

23.98

Held after

63.03K

Exercisable

4/8/2026

Stock Option (Right to Buy)

Direct
M · Option Exercise
Converts to

Common Stock

9.62K shares

Shares

9.62K

Strike price

20.02

Held after

10.59K

Exercisable

4/8/2026

Stock Option (Right to Buy)

Direct
M · Option Exercise
Converts to

Common Stock

19.34K shares

Shares

19.34K

Strike price

19.64

Held after

65.98K

Exercisable

4/8/2026
KNIGHT JEFF E. — Insider Transaction (Form 4) Filed Apr 10, 2026 | Finecho